Para-hydrogen labeled agents and their use in magnetic resonance imaging
AssigneeAmersham Health AS
InventorsKlaes Golman, Oskar Axelsson, Haukur Johanneson, Charlotte Olofsson, Sven Mansson, Stefan Petersson
Life of this patent
Estimating the term…
Loading patent…
AssigneeAmersham Health AS
InventorsKlaes Golman, Oskar Axelsson, Haukur Johanneson, Charlotte Olofsson, Sven Mansson, Stefan Petersson
Estimating the term…
The invention provides a method of magnetic resonance investigation of a sample, said method comprising: (i) reacting para-hydrogen enriched hydrogen with a hydrogenatable MR imaging agent precursor containing a non-hydrogen non-zero nuclear spin nucleus to produce a hydrogenated MR imaging agent; (ii) administering said hydrogenated MR imaging agent to said sample; (iii) exposing said sample to radiation of a frequency selected to excite nuclear spin transitions of said non-zero nuclear spin nucleus in said hydrogenated MR imaging agent; (v) detecting magnetic resonance signals of said non-zero nuclear spin nucleus from said sample; and (vi) optionally, generating an image or biological functional data or dynamic flow data from said detected signals.
A method of magnetic resonance investigation of a sample, said method comprising:
A method as claimed in any of the preceding claims wherein said MR imaging agent precursor contains nuclei selected from F, Li, C, N, Si and P nuclei.
Use of para-hydrogen enriched hydrogen in the manufacture of an MR imaging agent for non-proton MR imaging of a sample.
Use of para-hydrogen enriched hydrogen in MR imaging of a sample.
A precursor compound:
A reporter compound:
A physiologically tolerable MR imaging agent composition comprising an MR imaging agent together with one or more physiologically tolerable carriers or excipients, said imaging agent containing non-hydrogen nuclei having a nuclear spin of ½, characterised in that said nuclei are polarized such that their nmr signal intensity is equivalent to a signal intensity achievable in a magnetic field of at least 0.1T.
An apparatus for hydrogenation comprising:
The use of para-hydrogen enriched hydrogen in the manufacture of an MR imaging agent for use in a method of diagnosis involving generation of an MR image by non-proton MR imaging.
The use of a hydrogenatable compound containing a non hydrogen non zero nuclear spin nucleus in the manufacture of an MR imaging agent for use in a method of diagnosis involving generation of an MR image by non-proton MR imaging, said manufacture involving hydrogenation of said compound with para-hydrogen enriched hydrogen.
Dependencies are inferred from the claim text.